James A F, Ramsey J E, Reynolds A M, Hendry B M, Shattock M J
Cardiac Physiology, Centre for Cardiovascular Biology and Medicine, The Rayne Institute, St. Thomas' Hospital, Lambeth Palace Road, London, SE1 7EH, United Kingdom.
Biochem Biophys Res Commun. 2001 Jun 22;284(4):1048-55. doi: 10.1006/bbrc.2001.5083.
It has been suggested that the positive inotropic effect of the vasoactive peptide hormone, endothelin-1 (ET-1), involves inhibition of cardiac K(+) currents. In order to identify the K(+) currents modulated by ET-1, the outward K(+) currents of isolated rat ventricular myocytes were investigated using whole-cell patch-clamp recording techniques. Outward currents were elicited by depolarisation to +40 mV for 200 ms from the holding potential of -60 mV. Currents activated rapidly, reaching a peak (I(pk)) of 1310 +/- 115 pA and subsequently inactivating to an outward current level of 1063 +/- 122 pA at the end of the voltage-pulse (I(late)) (n = 11). ET-1 (20 nM) reduced I(pk) by 247.6 +/- 60.7 pA (n = 11, P < 0.01) and reduced I(late) by 323.2 +/- 43.9 pA (P < 0.001). The effects of ET-1 were abolished in the presence of the nonselective ET receptor antagonist, PD 142893 (10 microM, n = 5). Outward currents were considerably reduced and the effects of ET-1 were not observed when K(+) was replaced with Cs(+) in the experimental solutions; this indicates that ET-1 modulated K(+)-selective currents. A double-pulse protocol was used to investigate the inactivation of the currents. The voltage-dependent inactivation of the currents from potentials positive to -80 mV was fitted by a Boltzmann equation revealing the existence of an inactivating transient outward component (I(to)) and a noninactivating steady-state component (I(ss)). ET-1 markedly inhibited I(ss) by 43.0 +/- 3.8% (P < 0.001, n = 7) and shifted the voltage-dependent inactivation of I(to) by +3.3 +/- 1.2 mV (P < 0.05). Although ET-1 had little effect on the onset of inactivation of the currents elicited from a conditioning potential of -70 mV, the time-independent noninactivating component of the currents was markedly inhibited. In conclusion, the predominant effect of ET-1 was to inhibit a noninactivating steady-state background K(+) current (I(ss)). These results are consistent with the hypothesis that I(ss) inhibition contributes to the inotropic effects of ET-1.
有人提出,血管活性肽激素内皮素 -1(ET -1)的正性肌力作用涉及对心脏钾离子电流的抑制。为了确定受ET -1调节的钾离子电流,采用全细胞膜片钳记录技术研究了分离的大鼠心室肌细胞的外向钾离子电流。外向电流通过从 -60 mV的钳制电位去极化至 +40 mV持续200 ms来诱发。电流迅速激活,在电压脉冲结束时达到峰值(I(pk))1310±115 pA,随后失活至外向电流水平1063±122 pA(I(late))(n = 11)。ET -1(20 nM)使I(pk)降低247.6±60.7 pA(n = 11,P < 0.01),使I(late)降低323.2±43.9 pA(P < 0.001)。在非选择性ET受体拮抗剂PD 142893(10 μM,n = 5)存在的情况下,ET -1的作用被消除。当实验溶液中的钾离子被铯离子取代时,外向电流显著降低,且未观察到ET -1的作用;这表明ET -1调节钾离子选择性电流。采用双脉冲方案研究电流的失活。从高于 -80 mV的电位开始的电流的电压依赖性失活通过玻尔兹曼方程拟合,揭示存在一个失活的瞬时外向成分(I(to))和一个非失活的稳态成分(I(ss))。ET -1显著抑制I(ss)达43.0±3.8%(P < 0.001,n = 7),并使I(to) 的电压依赖性失活向正方向移动3.3±1.2 mV(P < 0.05)。尽管ET -1对从 -70 mV的预处理电位诱发的电流的失活起始影响很小,但电流的时间无关性非失活成分受到显著抑制。总之,ET -1的主要作用是抑制非失活的稳态背景钾离子电流(I(ss))。这些结果与I(ss)抑制促成ET -1的正性肌力作用这一假说一致。